World's Best Scientists 2026 revealed!
Stefano Colloca

Stefano Colloca

D-Index & Metrics

Immunology

D-Index
47
Citations
8842
World Ranking
4516
National Ranking
191

Overview

Stefano Colloca is affiliated with Reithera in Italy and has a research focus spanning multiple fields within medicine and molecular biology. Their work notably intersects immunology, infectious diseases, genetics, and oncology.

Their main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Immunology and Microbiology

Subfields of their research cover:

  • Infectious Diseases
  • Immunology
  • Molecular Biology
  • Genetics
  • Oncology

Main topics addressed in their research are:

  • SARS-CoV-2 and COVID-19 Research
  • Virus-based gene therapy research
  • Immunotherapy and Immune Responses
  • Vaccines and immunoinformatics approaches
  • CAR-T cell therapy research
  • Rabies epidemiology and control
  • Viral Infections and Outbreaks Research

Stefano Colloca has published extensively, with notable papers including:

  • "A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability," 2020, Cancer Research
  • "Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19," 2021, Molecular Therapy
  • "MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans," 2020, Science Translational Medicine
  • "GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults," 2021, Science Translational Medicine
  • "A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C," 2020, PLoS neglected tropical diseases

Frequent coauthors who have collaborated with Colloca include:

  • Stefania Capone
  • Antonella Folgori
  • Alessandra M. Contino
  • Alessandra Vitelli
  • Simone Battella

Their research has appeared regularly in several publication venues, with multiple contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Vaccines
  • Science Translational Medicine
  • PLoS neglected tropical diseases
  • Vaccines

Best Publications

  • Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man

    Eleanor Barnes;Eleanor Barnes;Antonella Folgori;Stefania Capone;Leo Swadling

  • Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

    Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  • A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

    Antonella Folgori;Stefania Capone;Lionello Ruggeri;Annalisa Meola

  • A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

    Leo Swadling;Stefania Capone;Richard D. Antrobus;Anthony Brown

  • Chimpanzee Adenovirus Vector Ebola Vaccine

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Emily E. Coates

  • Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

    Katie J Ewer;Geraldine A O'Hara;Christopher J A Duncan;Katharine A Collins

  • Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

    Stefano Colloca;Eleanor Barnes;Antonella Folgori;Virginia Ammendola

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Prateek Choudhary

  • Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

    Geraldine A. O’Hara;Christopher J. A. Duncan;Katie J. Ewer;Katharine A. Collins

  • Prime-boost vectored malaria vaccines: progress and prospects.

    Adrian V S Hill;Arturo Reyes-Sandoval;Geraldine O'Hara;Katie Ewer

  • Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1

    Nicola Borthwick;Tina Ahmed;Beatrice Ondondo;Peter Hayes

  • Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Laura Novik

  • Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T-Cell Responses

    Arturo Reyes-Sandoval;Tamara Berthoud;Nicola Alder;Loredana Siani

  • Phase Ia Clinical Evaluation of the Plasmodium Falciparum Blood-Stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Katharine A Collins

  • Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors

    Susanne H. Sheehy;Christopher J. A. Duncan;Sean C. Elias;Sumi Biswas

  • Chimpanzee adenovirus vaccine carriers

    Agostino Cirillo;Stefano Colloca;Bruno Bruni Ercole;Annalisa Meola

  • Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

    Susanne H. Hodgson;Katie J. Ewer;Carly M. Bliss;Nick J. Edwards

  • A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

    Mohamed Osman;Anoop Mistry;Ada Keding;Rhian Gabe

  • Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

    C A Green;E Scarselli;C J Sande;A J Thompson

Frequent Co-Authors

Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II
Riccardo Cortese
Riccardo Cortese Schering-Plough
Antonella Folgori
Antonella Folgori University of Oxford
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Katie J. Ewer
Katie J. Ewer University of Oxford
Simon J. Draper
Simon J. Draper University of Oxford
Gennaro Ciliberto
Gennaro Ciliberto Magna Graecia University
Ian D. Poulton
Ian D. Poulton University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology and healthcare, pursuing related online degrees offers flexible options to advance your career. Many professionals start with online nursing programs for non nurses, which provide foundational clinical knowledge and skills without requiring prior nursing experience.

If you're looking to accelerate your education, accelerated BSN programs for non nurses allow you to quickly earn a Bachelor of Science in Nursing. These programs are designed to transition non-nurses into nursing roles and open pathways into immunology-related practice areas.

For those seeking quicker entry into nursing, fastest and easiest LPN programs offer a practical route to working in healthcare settings. LPNs can gain valuable hands-on experience, which is beneficial for specialization later on.

Finally, advancing to higher clinical roles is possible through easiest nurse practitioner program options. Nurse practitioners often engage directly in immunology-related diagnostics and patient care, making these programs a strong career step for those passionate about immunology.

Best Scientists Citing Stefano Colloca

Trending Scientists

Recently Published Articles